The Role of CCR4 in Skin Lymphocyte Homing and Immunity

CCR4 在皮肤淋巴细胞归巢和免疫中的作用

基本信息

  • 批准号:
    6755999
  • 负责人:
  • 金额:
    $ 31.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-08-01 至 2005-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chemoattractant cytokines (chemokines) are important mediators of lymphocyte trafficking from the circulation into sites of tissue damage and inflammation, and into secondary lymphoid organs. Certain chemokines rapidly trigger lymphocyte integrins, causing increased avidity with endothelial ligands, resulting in arrest of the lymphocyte on endothelial cells close to the chemokine source. Gradients of chemokine molecules can also attract arrested cells through the endothelium and into the surrounding tissue. A variety of chemokines are differentially expressed in various tissue types, suggesting a role in the differential homing of specific lymphocyte subsets to various types of tissue. We have found (in the human system) that the chemokines TARC and MDC efficiently attract circulating systemic memory T cells, especially skin-homing T cells expressing the cutaneous lymphocyte antigen, CLA. In contrast, intestinal (a4B7+) memory and naive T cells respond poorly. Immunohistochemistry reveals anti-TARC reactivity with venules involved in lymphocyte trafficking in chronically inflamed skin, but not in the gastrointestinal lamina propria, suggesting a potential role in circulating CLA+ lymphocyte recognition of skin vasculature. Consistent with this, TARC triggers integrin-dependent adhesion of CLA+ (but not a4B7hi intestinal) memory T cells to ICAM-1; and mediates rapid integrin-dependent arrest of lymphocytes rolling on the vascular CLA receptor, E-selectin, under physiologic flow conditions. The results suggest a fundamental role for TARC and its lymphocyte receptor CCR4 in lymphocyte-endothelial cell recognition and in differential trafficking of lymphocyte populations responsible for systemic vs. intestinal immunity. In order to define this role in detail, here we shall characterize CCR4 expression and responsiveness to TARC and MDC among specialized subsets of lymphocytes in man (Aim 1). We will determine if the preferential effects of TARC and MDC on systemic vs. mucosal lymphocytes are also observed in the mouse, and will ask if these responses are CCR4-dependent (Aim 2). The availability of a mutant CCR4-deficient mouse line will allow us to explore the role of this receptor in targeted lymphocyte homing to inflamed skin (Aim 3) and its role in the inflammation process in models of DTH and autoimmune psoriasis (Aim 4). Monoclonal antibodies to mouse CCR4 and its ligands will facilitate these studies (Aim 5). These studies promise to define a critical component of lymphocyte recruitment to systemic sites inflammation, and may lead to novel therapeutic approaches in cutaneous (i.e. psoriasis) and other inflammatory diseases.
描述(由申请人提供):化学引诱细胞因子(趋化因子)是 淋巴细胞从循环运输到部位的重要介质 组织损伤和炎症,并进入次级淋巴器官。某些 趋化因子迅速触发淋巴细胞整合素,导致与 内皮配体,导致内皮细胞上的淋巴细胞停滞 靠近趋化因子的来源趋化因子分子的衍生物也可以 通过内皮细胞吸引停滞的细胞进入周围组织。 多种趋化因子在各种组织类型中差异表达, 提示在特异性淋巴细胞亚群的差异归巢中的作用, 各种组织。我们发现(在人类系统中), 趋化因子TARC和MDC有效地吸引循环系统记忆T 细胞,特别是表达皮肤淋巴细胞的皮肤归巢T细胞 抗原,CLA。相比之下,肠(a4 B7+)记忆和初始T细胞应答 很糟糕免疫组织化学显示抗TARC反应与小静脉参与 淋巴细胞在慢性炎症皮肤中的运输,但在 胃肠道固有层,表明在循环中的潜在作用 皮肤脉管系统的CLA+淋巴细胞识别。与此同时,TARC 触发CLA+(但不是a4 B7 hi肠)记忆的整合素依赖性粘附 T细胞的ICAM-1;并介导淋巴细胞的快速整合素依赖性停滞 在生理流量下,在血管CLA受体E-选择素上滚动 条件结果表明,TARC及其淋巴细胞的基本作用 受体CCR 4在淋巴细胞-内皮细胞识别和分化中的作用 淋巴细胞群的运输负责全身与肠道 免疫力为了详细定义这一角色,我们将在这里描述 CCR 4表达和对TARC和MDC的反应性在特化的 人淋巴细胞(Aim 1)。我们将确定, 还观察到全身淋巴细胞与粘膜淋巴细胞上的TARC和MDC, 小鼠,并将询问这些反应是否是CCR 4依赖性的(目标2)。的 突变型CCR 4缺陷小鼠系的可用性将使我们能够探索 该受体在靶向淋巴细胞归巢至发炎皮肤中的作用(目的3) 及其在DTH和自身免疫模型中的炎症过程中的作用 银屑病(目的4)。针对小鼠CCR 4及其配体的单克隆抗体将 促进这些研究(目标5)。这些研究承诺定义一个关键的 淋巴细胞募集到全身部位炎症的组分,并且可能 导致皮肤(即银屑病)和其他疾病的新治疗方法 炎症性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James J. Campbell其他文献

Erratum for vol. 101, p. 1200
  • DOI:
    10.1182/blood-2003-01-0200
  • 发表时间:
    2003-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dulce Soler;Tricia L. Humphreys;Stanley M. Spinola;James J. Campbell
  • 通讯作者:
    James J. Campbell
T<sub>regs</sub> control B-cell life and death
  • DOI:
    10.1182/blood-2006-03-005215
  • 发表时间:
    2006-05-15
  • 期刊:
  • 影响因子:
  • 作者:
    James J. Campbell
  • 通讯作者:
    James J. Campbell

James J. Campbell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James J. Campbell', 18)}}的其他基金

Influence of Chemokine Receptors on T Cell Cytokine Profiles in Skin
趋化因子受体对皮肤 T 细胞细胞因子谱的影响
  • 批准号:
    8225940
  • 财政年份:
    2012
  • 资助金额:
    $ 31.6万
  • 项目类别:
Chemokine Receptor CCR7 In Tissue-Specific T Cell Imprinting and Autoimmunity
组织特异性 T 细胞印迹和自身免疫中的趋化因子受体 CCR7
  • 批准号:
    8272537
  • 财政年份:
    2011
  • 资助金额:
    $ 31.6万
  • 项目类别:
Chemokine Receptor CCR7 In Tissue-Specific T Cell Imprinting and Autoimmunity
组织特异性 T 细胞印记和自身免疫中的趋化因子受体 CCR7
  • 批准号:
    8190270
  • 财政年份:
    2011
  • 资助金额:
    $ 31.6万
  • 项目类别:
Loading Skin-Derived Antigen on Dendritic Cells in Vivo for T Responses in Vitro
将皮肤源性抗原加载到体内树突状细胞上以实现体外 T 反应
  • 批准号:
    7707028
  • 财政年份:
    2009
  • 资助金额:
    $ 31.6万
  • 项目类别:
Loading Skin-Derived Antigen on Dendritic Cells in Vivo for T Responses in Vitro
将皮肤源性抗原加载到体内树突状细胞上以实现体外 T 反应
  • 批准号:
    7860362
  • 财政年份:
    2009
  • 资助金额:
    $ 31.6万
  • 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
  • 批准号:
    6331894
  • 财政年份:
    2001
  • 资助金额:
    $ 31.6万
  • 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
  • 批准号:
    6611429
  • 财政年份:
    2001
  • 资助金额:
    $ 31.6万
  • 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
  • 批准号:
    6511204
  • 财政年份:
    2001
  • 资助金额:
    $ 31.6万
  • 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
  • 批准号:
    7285873
  • 财政年份:
    2000
  • 资助金额:
    $ 31.6万
  • 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
  • 批准号:
    7151962
  • 财政年份:
    2000
  • 资助金额:
    $ 31.6万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了